These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1234 related articles for article (PubMed ID: 24218310)
1. Value of EUS in early detection of pancreatic ductal adenocarcinomas in patients with intraductal papillary mucinous neoplasms. Kamata K; Kitano M; Kudo M; Sakamoto H; Kadosaka K; Miyata T; Imai H; Maekawa K; Chikugo T; Kumano M; Hyodo T; Murakami T; Chiba Y; Takeyama Y Endoscopy; 2014 Jan; 46(1):22-9. PubMed ID: 24218310 [TBL] [Abstract][Full Text] [Related]
2. Role of endoscopic retrograde pancreatography for early detection of pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasm of the pancreas. Ohtsuka T; Ideno N; Aso T; Nagayoshi Y; Kono H; Mori Y; Takahata S; Oda Y; Aishima S; Igarashi H; Ito T; Ishigami K; Nakamura M; Mizumoto K; Tanaka M J Hepatobiliary Pancreat Sci; 2013 Mar; 20(3):356-61. PubMed ID: 22878836 [TBL] [Abstract][Full Text] [Related]
3. Development of pancreatic cancers during long-term follow-up of side-branch intraductal papillary mucinous neoplasms. Sawai Y; Yamao K; Bhatia V; Chiba T; Mizuno N; Sawaki A; Takahashi K; Tajika M; Shimizu Y; Yatabe Y; Yanagisawa A Endoscopy; 2010 Dec; 42(12):1077-84. PubMed ID: 21120776 [TBL] [Abstract][Full Text] [Related]
4. Value of additional endoscopic ultrasonography for surveillance after surgical removal of intraductal papillary mucinous neoplasms. Kamata K; Takenaka M; Minaga K; Omoto S; Miyata T; Yamao K; Imai H; Nakai A; Tanaka H; Chiba Y; Watanabe T; Sakurai T; Nishida N; Chikugo T; Matsumoto I; Takeyama Y; Kitano M; Kudo M Dig Endosc; 2018 Sep; 30(5):659-666. PubMed ID: 29675938 [TBL] [Abstract][Full Text] [Related]
5. Development of ductal carcinoma of the pancreas during follow-up of branch duct intraductal papillary mucinous neoplasm of the pancreas. Uehara H; Nakaizumi A; Ishikawa O; Iishi H; Tatsumi K; Takakura R; Ishida T; Takano Y; Tanaka S; Takenaka A Gut; 2008 Nov; 57(11):1561-5. PubMed ID: 18477671 [TBL] [Abstract][Full Text] [Related]
6. Differential diagnosis of benign and malignant branch duct intraductal papillary mucinous neoplasm using contrast-enhanced endoscopic ultrasonography. Harima H; Kaino S; Shinoda S; Kawano M; Suenaga S; Sakaida I World J Gastroenterol; 2015 May; 21(20):6252-60. PubMed ID: 26034360 [TBL] [Abstract][Full Text] [Related]
7. Appropriate indications of initial endoscopic ultrasound evaluation for detecting mural nodules in branch duct intraductal papillary mucinous neoplasms of the pancreas. Kim YI; Woo SM; Lee WJ; Han SS; Park SJ; Kim TH; Koh YH; Hong EK Scand J Gastroenterol; 2013 May; 48(5):610-6. PubMed ID: 23597152 [TBL] [Abstract][Full Text] [Related]
8. Comparison of International Consensus Guidelines versus 18-FDG PET in detecting malignancy of intraductal papillary mucinous neoplasms of the pancreas. Pedrazzoli S; Sperti C; Pasquali C; Bissoli S; Chierichetti F Ann Surg; 2011 Dec; 254(6):971-6. PubMed ID: 22076067 [TBL] [Abstract][Full Text] [Related]
9. Management of branch-duct intraductal papillary mucinous neoplasms: a large single-center study to assess predictors of malignancy and long-term outcomes. Ridtitid W; DeWitt JM; Schmidt CM; Roch A; Stuart JS; Sherman S; Al-Haddad MA Gastrointest Endosc; 2016 Sep; 84(3):436-45. PubMed ID: 26905937 [TBL] [Abstract][Full Text] [Related]
10. Malignant transformation of branch duct-type intraductal papillary mucinous neoplasms of the pancreas based on contrast-enhanced endoscopic ultrasonography morphological changes: focus on malignant transformation of intraductal papillary mucinous neoplasm itself. Ohno E; Itoh A; Kawashima H; Ishikawa T; Matsubara H; Itoh Y; Nakamura Y; Hiramatsu T; Nakamura M; Miyahara R; Ohmiya N; Ishigami M; Katano Y; Goto H; Hirooka Y Pancreas; 2012 Aug; 41(6):855-62. PubMed ID: 22481289 [TBL] [Abstract][Full Text] [Related]
11. Intraductal papillary mucinous neoplasms of the pancreas with distinct pancreatic ductal adenocarcinomas are frequently of gastric subtype. Ideno N; Ohtsuka T; Kono H; Fujiwara K; Oda Y; Aishima S; Ito T; Ishigami K; Tokunaga S; Ohuchida K; Takahata S; Nakamura M; Mizumoto K; Tanaka M Ann Surg; 2013 Jul; 258(1):141-51. PubMed ID: 23532108 [TBL] [Abstract][Full Text] [Related]
12. Long-term Risk of Malignancy in Branch-Duct Intraductal Papillary Mucinous Neoplasms. Oyama H; Tada M; Takagi K; Tateishi K; Hamada T; Nakai Y; Hakuta R; Ijichi H; Ishigaki K; Kanai S; Kogure H; Mizuno S; Saito K; Saito T; Sato T; Suzuki T; Takahara N; Morishita Y; Arita J; Hasegawa K; Tanaka M; Fukayama M; Koike K Gastroenterology; 2020 Jan; 158(1):226-237.e5. PubMed ID: 31473224 [TBL] [Abstract][Full Text] [Related]
13. Does a family history of pancreatic ductal adenocarcinoma and cyst size influence the follow-up strategy for intraductal papillary mucinous neoplasms of the pancreas? Mandai K; Uno K; Yasuda K Pancreas; 2014 Aug; 43(6):917-21. PubMed ID: 24743378 [TBL] [Abstract][Full Text] [Related]
14. Invasive carcinoma derived from "flat type" branch duct intraductal papillary mucinous neoplasms of the pancreas: impact of classification according to the height of mural nodule on endoscopic ultrasonography. Koshita S; Fujita N; Noda Y; Kobayashi G; Ito K; Horaguchi J; Kanno Y; Ogawa T; Masu K; Michikawa Y; Iwashita Y; Sawai T; Uzuki M; Fujishima F J Hepatobiliary Pancreat Sci; 2015 Apr; 22(4):301-9. PubMed ID: 25488889 [TBL] [Abstract][Full Text] [Related]
15. Pancreatic neuroendocrine tumors among patients with intraductal papillary mucinous neoplasms: real association or just a coincidence? Gill KR; Scimeca D; Stauffer J; Krishna M; Woodward TA; Jamil LH; Wallace MB; Nguyen JH; Raimondo M JOP; 2009 Sep; 10(5):515-7. PubMed ID: 19734627 [TBL] [Abstract][Full Text] [Related]
16. Chronic Pancreatitis Finding by Endoscopic Ultrasonography in the Pancreatic Parenchyma of Intraductal Papillary Mucinous Neoplasms Is Associated with Invasive Intraductal Papillary Mucinous Carcinoma. Takenaka M; Masuda A; Shiomi H; Yagi Y; Zen Y; Sakai A; Kobayashi T; Arisaka Y; Okabe Y; Kutsumi H; Toyama H; Fukumoto T; Ku Y; Kudo M; Azuma T Oncology; 2017; 93 Suppl 1():61-68. PubMed ID: 29258092 [TBL] [Abstract][Full Text] [Related]
17. Mode of progression of intraductal papillary-mucinous tumor of the pancreas: analysis of patients with follow-up by EUS. Kobayashi G; Fujita N; Noda Y; Ito K; Horaguchi J; Takasawa O; Akaishi S; Tsuchiya T; Kobari M J Gastroenterol; 2005 Jul; 40(7):744-51. PubMed ID: 16082592 [TBL] [Abstract][Full Text] [Related]
18. Risk of Neoplastic Progression in Individuals at High Risk for Pancreatic Cancer Undergoing Long-term Surveillance. Canto MI; Almario JA; Schulick RD; Yeo CJ; Klein A; Blackford A; Shin EJ; Sanyal A; Yenokyan G; Lennon AM; Kamel IR; Fishman EK; Wolfgang C; Weiss M; Hruban RH; Goggins M Gastroenterology; 2018 Sep; 155(3):740-751.e2. PubMed ID: 29803839 [TBL] [Abstract][Full Text] [Related]
19. Association between hyperechogenic pancreas and pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasms. Mandai K; Uno K; Nakase K; Kawamura T; Yasuda K J Med Ultrason (2001); 2019 Oct; 46(4):435-439. PubMed ID: 31069577 [TBL] [Abstract][Full Text] [Related]
20. Intraductal papillary mucinous neoplasms of the pancreas: differentiation of malignant and benign tumors by endoscopic ultrasound findings of mural nodules. Ohno E; Hirooka Y; Itoh A; Ishigami M; Katano Y; Ohmiya N; Niwa Y; Goto H Ann Surg; 2009 Apr; 249(4):628-34. PubMed ID: 19300203 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]